In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading ->
US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading ->